CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

CADTH Announces New Members to Its Health Technology Expert Review Panel

September 10, 2014
Wednesday, September 10, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members to the Health Technology Expert Review Panel: Jenny Basran, MD, FRCPC — Internist Geriatrician and Associate Professor in the Department of Medicine at the University of Saskatchewan Leslie Anne Ca...

CADTH Announces New Chair and Vice-Chair of the Canadian Drug Expert Committee

September 3, 2014
September 3, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced changes to the leadership of the Canadian Drug Expert Committee. Dr. Lindsay Nicolle has been appointed the new Chair of the committee and Dr. James Silvius has been appointed Vice-Chair. Their appointments are for two and three-year terms respectively a...

Advisory Panel on Healthcare Innovation

June 24, 2014
June 24, 2014 - The creation of an Advisory Panel on Healthcare Innovation, announced earlier today by federal Health Minister Rona Ambrose, will help ensure all Canadians benefit from health innovation, said Dr. Brian O’Rourke, President and CEO of CADTH, the pan-Canadian health technology assessment agency. “There are two positive aspects to ...

Pilot Process for Receiving Patient Group Input Submissions for Therapeutic Reviews

August 20, 2013
The Canadian Agency for Drugs and Technologies in Health (CADTH) has implemented a pilot process for receiving patient input submissions for therapeutic reviews from patient groups. Patient groups are invited to provide experiences and perspectives about living with the condition for which the drugs included in the therapeutic review are indicat...